PSCA represents an associated glycophosphatidylinositol (GPI)-anchored cell surface antigen [16,17,18,19], which is expressed in normal prostate-specific tissue and overexpressed in prostate cancer specimens including both high-grade prostatic intraepithelial neoplasia and androgen-dependent/independent tumors [19]. Here, PSCA is linked to prostate carcinoma.